DK0680967T3 - Nye forbindelser afledt af erythromycin, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler - Google Patents

Nye forbindelser afledt af erythromycin, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler

Info

Publication number
DK0680967T3
DK0680967T3 DK95400987T DK95400987T DK0680967T3 DK 0680967 T3 DK0680967 T3 DK 0680967T3 DK 95400987 T DK95400987 T DK 95400987T DK 95400987 T DK95400987 T DK 95400987T DK 0680967 T3 DK0680967 T3 DK 0680967T3
Authority
DK
Denmark
Prior art keywords
erythromycin
drugs
preparation
methods
new compounds
Prior art date
Application number
DK95400987T
Other languages
English (en)
Inventor
Martret Odile Le
D Ambrieres Solange Gouin
Constantin Agouridas
Alexis Denis
Jean-Francois Chantot
Jean-Fran Ois Chantot
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DK0680967T3 publication Critical patent/DK0680967T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK95400987T 1994-05-03 1995-05-02 Nye forbindelser afledt af erythromycin, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler DK0680967T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9405368A FR2719587B1 (fr) 1994-05-03 1994-05-03 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Publications (1)

Publication Number Publication Date
DK0680967T3 true DK0680967T3 (da) 1999-06-23

Family

ID=9462785

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95400987T DK0680967T3 (da) 1994-05-03 1995-05-02 Nye forbindelser afledt af erythromycin, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler

Country Status (43)

Country Link
US (2) US5635485A (da)
EP (1) EP0680967B1 (da)
JP (4) JP2992540B2 (da)
KR (1) KR100312267B1 (da)
CN (2) CN1052984C (da)
AP (1) AP558A (da)
AT (1) ATE172203T1 (da)
AU (1) AU684027B2 (da)
BG (1) BG63087B1 (da)
BR (1) BR9507700A (da)
CA (1) CA2189271C (da)
CZ (1) CZ293455B6 (da)
DE (2) DE69505296T2 (da)
DK (1) DK0680967T3 (da)
DZ (1) DZ1878A1 (da)
EE (1) EE03263B1 (da)
ES (1) ES2122472T3 (da)
FI (1) FI111263B (da)
FR (1) FR2719587B1 (da)
GE (1) GEP19991538B (da)
HK (1) HK1010732A1 (da)
HU (2) HU227493B1 (da)
IL (1) IL113245A (da)
LU (1) LU90872I2 (da)
LV (1) LV11739B (da)
MA (1) MA23534A1 (da)
MD (1) MD1233C2 (da)
NL (1) NL300077I1 (da)
NO (2) NO308853B1 (da)
NZ (1) NZ285416A (da)
OA (1) OA10319A (da)
PL (1) PL182034B1 (da)
RO (1) RO113350B1 (da)
RU (1) RU2144036C1 (da)
SI (1) SI0680967T1 (da)
SK (1) SK281707B6 (da)
TJ (1) TJ313B (da)
TN (1) TNSN95049A1 (da)
TW (1) TW341573B (da)
UA (1) UA51618C2 (da)
WO (1) WO1995029929A1 (da)
YU (1) YU49235B (da)
ZA (1) ZA953501B (da)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708005A (en) * 1995-06-27 1998-01-13 Takeda Chemical Industries, Ltd. Quinolines, their production and use
FR2742757B1 (fr) 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
EP1291352B1 (en) * 1996-09-04 2005-05-25 Abbott Laboratories 6-O-substituted ketolides having antibacterial activity
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
US5780605A (en) * 1997-09-08 1998-07-14 Abbott Laboratories 6,9-bridged erythromycin derivatives
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
EP1115732B1 (en) * 1998-09-22 2005-06-29 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2785612A1 (fr) * 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
ES2273964T3 (es) 1998-12-10 2007-05-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
ID30233A (id) * 1999-01-27 2001-11-15 Pfizer Prod Inc Antibiotika ketolida
FR2789392B1 (fr) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) * 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
AU775637B2 (en) 1999-04-16 2004-08-12 Kosan Biosciences, Inc. Macrolide antiinfective agents
MXPA01010521A (es) 1999-04-16 2003-08-19 Johnson & Johnson Antibacteriales de cetolidos.
PL352720A1 (en) * 1999-05-24 2003-09-08 Pfizer Products Inc. 13-methyl-erythromycin derivatives
FR2797875B1 (fr) * 1999-08-26 2001-10-19 Hoechst Marion Roussel Inc Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
BR0113472A (pt) * 2000-08-22 2003-07-01 Basilea Pharmaceutica Ag Macrolìdeos com atividade antibacteriana
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
AU2002316550A1 (en) * 2001-07-03 2003-01-21 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
US8063021B2 (en) * 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
US6995143B2 (en) 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
WO2004005313A2 (en) 2002-07-08 2004-01-15 Pliva - Istrazivacki Institut D.O.O. Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
US7091187B2 (en) 2002-07-08 2006-08-15 Pliva-Istrazivacki Institut D.O.O. Compounds, compositions and methods for treatment of inflammatory diseases and conditions
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
US6916934B2 (en) * 2003-02-11 2005-07-12 Aventis Pharma Deutschland Gmbh Process for preparing pyridine-substituted amino ketal derivatives
WO2004080391A2 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
CA2523541A1 (en) * 2003-04-25 2004-11-11 Chiron Corporation Novel ketolide derivatives
US20050101548A1 (en) * 2003-09-12 2005-05-12 Xiaodong Lin Antimicrobial derivatives
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
CN102816194A (zh) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
WO2005105821A2 (en) * 2004-04-28 2005-11-10 Alembic Limited Process for the preparation of telithromycin
US20080287376A1 (en) * 2004-07-28 2008-11-20 Mohammad Salman Ketolide Derivatives as Antibacterial Agents
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
PL1836211T3 (pl) * 2004-12-21 2010-07-30 Pfizer Prod Inc Makrolidy
CN102290174A (zh) * 2005-02-08 2011-12-21 株式会社村田制作所 表面安装型负特性热敏电阻
FR2882522B1 (fr) 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
WO2006129257A2 (en) * 2005-05-30 2006-12-07 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
WO2007049296A2 (en) * 2005-10-28 2007-05-03 Alembic Limited Amorphous form of telithromycin
WO2007059307A2 (en) * 2005-11-15 2007-05-24 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of telithromycin
US20090005325A1 (en) * 2005-11-23 2009-01-01 Biswajit Bas Ketolide Derivatives as Antibacterial Agents
EP1960413A2 (en) * 2005-11-23 2008-08-27 Ranbaxy Laboratories Limited Macrolides derivatives as antibacterial agents
WO2007060627A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Use of macrolide derivatives for treating acne
US7595300B2 (en) 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
GB0600238D0 (en) * 2006-01-06 2006-02-15 Sandoz Ag Organic compounds
WO2007091393A1 (ja) * 2006-02-07 2007-08-16 Taisho Pharmaceutical Co., Ltd. １０ａ－アザライド化合物
CA2661538A1 (en) 2006-08-24 2008-02-28 Wockhardt Research Centre Novel macrolides and ketolides having antimicrobial activity
WO2008023383A1 (en) * 2006-08-25 2008-02-28 Alembic Limited Novel process for the preparation of telithromycin
ES2306590B1 (es) * 2006-12-15 2009-08-07 Ercros Industrial,S .A. Formas cristalinas i y ii de telitromicina.
WO2009019868A1 (ja) 2007-08-06 2009-02-12 Taisho Pharmaceutical Co., Ltd. １０ａ、１２位架橋型１０ａ－アザライド化合物
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
EP2937019B1 (en) 2007-09-20 2017-11-08 Herman Miller, Inc. Load support structure
US9453042B2 (en) 2007-10-25 2016-09-27 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US20110040078A1 (en) * 2007-10-25 2011-02-17 Siegfried Wolf Process for the production of telithromycin
WO2009139181A1 (ja) 2008-05-15 2009-11-19 大正製薬株式会社 ４員環構造を有する１０ａ－アザライド化合物
WO2010048600A1 (en) * 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
WO2010136971A1 (en) 2009-05-27 2010-12-02 Wockhardt Research Centre Ketolide compounds having antimicrobial activity
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
WO2011032052A1 (en) 2009-09-10 2011-03-17 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
DK2550286T3 (da) 2010-03-22 2016-02-29 Cempra Pharmaceuticals Inc Krystallinske former af et macrolid og anvendelser deraf
EP2571506B1 (en) 2010-05-20 2017-05-10 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
WO2012034058A1 (en) * 2010-09-10 2012-03-15 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
DK2673285T3 (da) 2010-12-09 2017-10-16 Wockhardt Ltd Ketolidforbindelser
AR085286A1 (es) 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
WO2012117357A2 (en) 2011-03-01 2012-09-07 Wockhardt Limited Process for preparation of ketolide intermediates
US8993739B2 (en) 2011-03-22 2015-03-31 Wockhardt Ltd. Process for preparation of ketolide compounds
RU2658050C2 (ru) 2012-03-27 2018-06-19 Семпра Фармасьютикалз, Инк. Парентеральные составы для введения макролидных антибиотиков
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN105524132B (zh) * 2014-09-30 2019-07-02 中国医学科学院药物研究所 含有喹啉取代基的红霉素a酮内酯类抗生素衍生物、其制备方法及应用
DE102015201783A1 (de) 2015-02-02 2016-08-04 Friedrich Baur Verfahren zur Herstellung eines Füllstoffs aus Textilfasern sowie Textil mit einem solchen Füllstoff
CN107129514B (zh) * 2016-03-02 2019-12-13 中国医学科学院药物研究所 红霉素a酮内酯类抗生素衍生物、其制备方法及应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
US4434174A (en) * 1980-02-11 1984-02-28 Berlex Laboratories, Inc. Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
EP0034116A3 (en) * 1980-02-11 1981-09-02 Berlex Laboratories, Inc. N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
US4568687A (en) * 1983-02-28 1986-02-04 American Cyanamid Company N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions
ZA84949B (en) * 1983-04-06 1984-09-26 American Cyanamid Co Substituted-n-(2-4-(1h-imidazol-1-yl)alkyl)substituted amides
US4489089A (en) * 1983-04-06 1984-12-18 American Cyanamid Company Substituted N-[ω-(1H-imidazol-1-yl)alkyl]-amides
AU573828B2 (en) * 1984-05-17 1988-06-23 E.R. Squibb & Sons, Inc. Tetrahydronaphthalenols
GB8425104D0 (en) * 1984-10-04 1984-11-07 Ici America Inc Amide derivatives
DE3540376A1 (de) * 1985-11-14 1987-05-21 Bayer Ag Verfahren zur inhibierung der wasserstoffinduzierten korrosion von metallischen werkstoffen
ATE106884T1 (de) * 1986-10-29 1994-06-15 Pfizer Verfahren zur herstellung von 2-(1-pentyl-3- guanidino)-4-(2-methyl-4-imidazolyl)thiazol und dessen kristallinisches dihydrochlorid-trihydrat.
DE3930669A1 (de) * 1989-09-14 1991-03-28 Basf Ag Verfahren zur herstellung von uretdiongruppen aufweisenden polyisocyanaten
JP2899028B2 (ja) * 1989-12-01 1999-06-02 協和醗酵工業株式会社 ジベンゾオキセピン誘導体
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
EP0559896B1 (en) * 1990-11-28 1997-08-27 Taisho Pharmaceutical Co. Ltd 6-o-methylerythromycin a derivative
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
TW444018B (en) * 1992-12-17 2001-07-01 Pfizer Pyrazolopyrimidines
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates

Also Published As

Publication number Publication date
YU27095A (sh) 1998-05-15
JP4750755B2 (ja) 2011-08-17
CZ293455B6 (cs) 2004-05-12
CN1229082A (zh) 1999-09-22
AP9500744A0 (en) 1995-07-31
BG100951A (en) 1997-08-29
ES2122472T3 (es) 1998-12-16
IL113245A0 (en) 1995-07-31
NO308853B1 (no) 2000-11-06
LV11739B (en) 1997-08-20
NL300077I1 (nl) 2002-03-01
JP2007269810A (ja) 2007-10-18
NO964654D0 (no) 1996-11-04
CA2189271A1 (fr) 1995-11-09
FI111263B (fi) 2003-06-30
FR2719587B1 (fr) 1996-07-12
JP2007045847A (ja) 2007-02-22
YU49235B (sh) 2004-12-31
LV11739A (lv) 1997-04-20
MA23534A1 (fr) 1995-12-31
TW341573B (en) 1998-10-01
EP0680967A1 (fr) 1995-11-08
JP3998828B2 (ja) 2007-10-31
DE10299001I2 (de) 2012-07-05
JP4658902B2 (ja) 2011-03-23
CN1151746A (zh) 1997-06-11
RU2144036C1 (ru) 2000-01-10
AU684027B2 (en) 1997-11-27
EE03263B1 (et) 2000-04-17
HUT75698A (en) 1997-05-28
DZ1878A1 (fr) 2002-02-17
HK1010732A1 (en) 1999-06-25
LU90872I2 (fr) 2002-03-12
US5635485A (en) 1997-06-03
ZA953501B (en) 1996-05-02
FI964395A0 (fi) 1996-10-31
HU219599B (hu) 2001-05-28
RO113350B1 (ro) 1998-06-30
FR2719587A1 (fr) 1995-11-10
GEP19991538B (en) 1999-03-05
CN1052984C (zh) 2000-05-31
SK140296A3 (en) 1998-04-08
BR9507700A (pt) 1997-08-19
IL113245A (en) 1999-11-30
TJ313B (en) 2001-08-06
FI964395A (fi) 1996-10-31
OA10319A (fr) 1997-10-07
AP558A (en) 1996-11-07
NZ285416A (en) 1997-07-27
TNSN95049A1 (fr) 1996-02-06
MD1233B1 (en) 1999-05-31
HU9904687D0 (en) 2000-03-28
CZ321496A3 (en) 1997-08-13
NO2001027I1 (no) 2002-01-28
JPH11152296A (ja) 1999-06-08
CN1088709C (zh) 2002-08-07
EP0680967B1 (fr) 1998-10-14
ATE172203T1 (de) 1998-10-15
KR100312267B1 (ko) 2002-06-22
SI0680967T1 (en) 1999-02-28
AU2449995A (en) 1995-11-29
MD1233C2 (ro) 2000-10-31
JPH0853489A (ja) 1996-02-27
WO1995029929A1 (fr) 1995-11-09
DE69505296D1 (de) 1998-11-19
HU227493B1 (en) 2011-07-28
HU9603038D0 (en) 1997-01-28
PL182034B1 (pl) 2001-10-31
JP2992540B2 (ja) 1999-12-20
DE10299001I1 (de) 2012-07-05
UA51618C2 (uk) 2002-12-16
MX9605208A (es) 1997-09-30
NO964654L (no) 1996-11-04
US6100404A (en) 2000-08-08
BG63087B1 (bg) 2001-03-30
CA2189271C (fr) 2005-12-27
PL317071A1 (en) 1997-03-03
SK281707B6 (sk) 2001-07-10
DE69505296T2 (de) 1999-04-22

Similar Documents

Publication Publication Date Title
DK0680967T3 (da) Nye forbindelser afledt af erythromycin, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
NO308361B1 (no) Nye erytromycinderivater, samt legemidler som inneholder slike
NO973923L (no) Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
DK0885234T3 (da) Nye erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK1016669T3 (da) Nye erythromycinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
DK0663913T3 (da) Nye substituerede pyrazolderivater, fremgangsmåder til deres fremstilling samt deres anvendelse som herbicider
NO982580D0 (no) Nye taxoider, deres fremstilling samt farmas°ystiske preparater inneholdende taxoidene
NO20032187D0 (no) Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene
NO20003496L (no) Nye aromatiske amider, fremgangsmÕte for fremstilling av disse, samt deres anvendelse som medisiner
NO995745D0 (no) Nye derivater av erytromycin, fremgangsmåte for fremstilling av disse, samt deres anvendelse som medikamenter
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
NO20023400L (no) Nye forbindelser med hypolidemisk og hypokolesteremisk virkning, deres fremstilling samt preparater inneholdendeforbindelsene
NO20003661D0 (no) Nye pentasakkarider, fremgangsmÕter for deres fremstilling og farmasøytiske preparater inneholdende de samme
NO960364L (no) Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
DK1015433T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oler, fremgangsmåder til fremstilling af disse og deres anvendelse som lægemidler
DK0782575T3 (da) Substituerede pyrazol-pyrazol-derivater, fremgangsmåde til deres fremsstilling samt deres anvendelse som midler med herbicid virkning
NO974563D0 (no) Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
NO960272L (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
DK0931088T3 (da) Nye erythromycinforbindelser, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
DK0864579T3 (da) Bismuthsalte af antibiotika fra moenomycingruppen, fremgangsmåde til fremstilling heraf, deres anvendelse samt lægemidler med indhold af sådanne salte
DK0446802T3 (da) Iminothiazoliner, deres fremstilling og anvendelse som herbicider samt mellemprodukter til deres fremstilling
DK0946579T3 (da) Nye forbindelser afledt af erythromcin, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO20024590L (no) Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling
NO985790D0 (no) Nye aromatiske derivater substituert med ribose, fremgangsmÕte for fremstilling derav samt deres anvendelse som medikamenter
DK0763535T3 (da) Piperidinylmethyloxazolidin-2-on-derivater, deres fremstilling og deres anvendelse som centralnervesystem-aktive forbindelser